Before you sell to, join or invest in Launchpad Therapeutics, Inc.
MentionFox check on Launchpad Therapeutics, Inc.: only 1 source on file so far (checked 10 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/launchpad-therapeutics-inc-form-d-22000001
Check Launchpad Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Launchpad Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2022-12-30.
Launchpad Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 30, 2022. The filing reports $10M sold. Its industry group is Biotechnology. It names Alexander Mayweg (Executive Officer, Director), Anna Kohlmann (Executive Officer), Ali Behbahani (Director) (SEC Form D, December 30, 2022).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Launchpad Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2022-12-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Launchpad Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Launchpad Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in December 2022, largest first.
Get an email when Launchpad Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Launchpad Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Launchpad Therapeutics, Inc. →Get the full cited report on Launchpad Therapeutics, Inc.
What the filing shows about Launchpad Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Launchpad Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Launchpad Therapeutics, Inc.'s address as One Main Street, 14TH Floor, Cambridge, MA 02142.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Launchpad Therapeutics, Inc. See pricing
Launchpad Therapeutics, Inc. is a registered filer with the SEC (CIK 1959206) and has filed since 2022-12-30. 1 filing is on record, the latest on 2022-12-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Launchpad Therapeutics, Inc.'s Form D of 2022-12-30 names Alexander Mayweg, Anna Kohlmann and Ali Behbahani as its officers, directors or promoters.
Its new offerings report $10M sold across 1 offering, as its own filings state.
Trailing twelve months. 755 filings in Biotechnology, totalled by week.
Alexander Mayweg is named as Executive Officer and Director on the Form D that Launchpad Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 3 people that filing names.
Anna Kohlmann is named as Executive Officer on the Form D that Launchpad Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 3 people that filing names.
Ali Behbahani is named as Director on the Form D that Launchpad Therapeutics, Inc. filed with the SEC on 30 December 2022, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2022-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Launchpad Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Launchpad Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Launchpad Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Launchpad Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Launchpad Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Launchpad Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/launchpad-therapeutics-inc-form-d-22000001